Through univariate and multivariate Cox analyses, the researchers identified six genes (C6orf222, CCNL1, CREBZF, GCKR, TFCP2, and VIPR2) that are differentially methylated and associated with prognosis in GC patients receiving chemotherapy. Here, TFCP2 is linked to gastric cancer.